Zealand Probability of Target Price Finishing Above 212.4

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;padding-top: 25px;;'>ZP</div>
ZEAL -- Denmark Stock  

DKK 259.00  0.20  0.08%

Zealand Pharma probability of target price tool provides mechanism to make assumptions about upside and downside potential of Zealand Pharma AS performance during a given time horizon utilizing its historical volatility.

Search Price Probability

 
Refresh
Please specify Zealand Pharma time horizon, a valid symbol (red box) and a target price (blue box) you would like Zealand Pharma odds to be computed. Check out Zealand Pharma Backtesting, Zealand Pharma Valuation, Zealand Pharma Correlation, Zealand Pharma Hype Analysis, Zealand Pharma Volatility, Zealand Pharma History as well as Zealand Pharma Performance.
Apply Odds

Zealand Pharma Target Price Odds to finish below 212.4

Current PriceHorizonTarget PriceOdds to drop to kr 212.40  or more in 30 days
 259.00 30 days 212.40 
about 27.42
Based on normal probability distribution, the odds of Zealand Pharma to drop to kr 212.40  or more in 30 days from now is about 27.42 (This Zealand Pharma AS probability density function shows the probability of Zealand Pharma Stock to fall within a particular range of prices over 30 days) . Probability of Zealand Pharma AS price to stay between kr 212.40  and its current price of kr259.0 at the end of the 30-day period is about 63.49 .
Assuming 30 trading days horizon, Zealand Pharma has beta of 0.3025 . This means as returns on market go up, Zealand Pharma average returns are expected to increase less than the benchmark. However during bear market, the loss on holding Zealand Pharma AS will be expected to be much smaller as well. Additionally The company has an alpha of 0.2524 implying that it can potentially generate 0.2524% excess return over DOW after adjusting for the inherited market risk (beta).
 Zealand Pharma Price Density 
      Price 
α
Alpha over DOW
=0.25
β
Beta against DOW=0.30
σ
Overall volatility
=24.03
Ir
Information ratio =0.031952

Zealand Pharma Alerts and Suggestions

Zealand Pharma AS has very high historical volatility over the last 30 days
The company reported revenue of 42.96 M. Net Loss for the year was (508.24 M) with profit before overhead, payroll, taxes, and interest of 40.92 M.
ZEALAND PHARMA has accumulated about 1.54 B in cash with (390.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 43.11.
Roughly 64.0% of the company outstanding shares are owned by institutional investors

Zealand PharmaPrice Density Drivers

Float Shares27.69M
Average Daily Volume Last 10 Day160.43k
Average Daily Volume In Three Month265.08k
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page